2016.11.29

Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed

Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed

Full text

2016.11.29

The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu

The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to attend 2016 Huaxing Capital healthcare and life science and technology leader summit

CHIPSCREEN BIOSCIENCES was invited to attend 2016 Huaxing Capital healthcare and life science and technology leader summit

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to DIA China's second drug research innovation conference

CHIPSCREEN BIOSCIENCES was invited to DIA China's second drug research innovation conference

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to attend the first China oncology clinical trial summit

CHIPSCREEN BIOSCIENCES was invited to attend the first China oncology clinical trial summit

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to attend international lymphoma special conference of 2016 CSC0 academic conference

CHIPSCREEN BIOSCIENCES was invited to attend international lymphoma special conference of 2016 CSC0 academic conference

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to attend the fifth China rare disease summit forum in 2016

CHIPSCREEN BIOSCIENCES was invited to attend the fifth China rare disease summit forum in 2016

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to participate in 2016 international clinical and translational medicine forum

CHIPSCREEN BIOSCIENCES was invited to participate in 2016 international clinical and translational medicine forum

Full text

2016.09.22

Dr. Lu Xianping from CHIPSCREEN BIOSCIENCES was invited to give lectures at the " lecture hall for 1,000 people" of China Pharmaceutical University.

Dr. Lu Xianping from CHIPSCREEN BIOSCIENCES was invited to give lectures at the " lecture hall for 1,000 people" of China Pharmaceutical University.

Full text

2016.09.22

Dr. Lu Xianping was invited to attend the 20th session of the lecture on understanding the future - challenging the forefront of science: life science and artificial intelligence

Dr. Lu Xianping was invited to attend the 20th session of the lecture on understanding the future - challenging the forefront of science: life science and artificial intelligence

Full text

2016.08.16

Dr. Lu Xianping was invited to attend the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun

Dr. Lu Xianping was invited to attend the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun

Full text

2016.08.16

Dr. Lu Xianping was invited to attend 2016 international biomedical innovation summit

Dr. Lu Xianping was invited to attend 2016 international biomedical innovation summit

Full text

2016.08.16

Dr. Lu Xianping was invited to attend the " pharmaceutical progress" development strategy elite seminar and editorial board meeting

Dr. Lu Xianping was invited to attend the " pharmaceutical progress" development strategy elite seminar and editorial board meeting

Full text

2016.07.12

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, was invited to attend the 18th Shanghai International Symposium on Biotechnology and Medicine

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, was invited to attend the 18th Shanghai International Symposium on Biotechnology and Medicine

Full text

2016.07.12

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, was invited to attend the second pharmaceutical frontier summit forum

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, was invited to attend the second pharmaceutical frontier summit forum

Full text

2016.06.25

Global " Shenzhen 100" list released. CHIPSCREEN BIOSCIENCES was selected as top 10 of sharp global company

Global " Shenzhen 100" list released. CHIPSCREEN BIOSCIENCES was selected as top 10 of sharp global company

Full text

2016.05.26

Chidamide is officially incorporated into Shenzhen local supplementary medical insurance drug list

Chidamide is officially incorporated into Shenzhen local supplementary medical insurance drug list

Full text

2016.05.10

CHIPSCREEN BIOSCIENCES was invited to participate in 2016 Pacific biology conference and 18th CABS annual conference

CHIPSCREEN BIOSCIENCES was invited to participate in 2016 Pacific biology conference and 18th CABS annual conference

Full text

2016.03.21

Dr. Lu Xianping was invited to attend the first Chinese medical epigenetics conference

Dr. Lu Xianping was invited to attend the first Chinese medical epigenetics conference

Full text

2016.03.14

Dr. Lu Xianping won the most influential innovative figure in Chinese medicine innovation

Dr. Lu Xianping won the most influential innovative figure in Chinese medicine innovation

Full text